Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways

Table 1

Influence of comorbidities in coronaviruses infections, SARS-CoV, MERS-CoV, and SARS-CoV-2 outbreaks.

	Diabetes (%)	Hypertension (%)	HD (%)	Obesity (%)	References
SARS	2.47–50.0	4.9–19.4	0.9–32.6	—	18–22
MERS	32.4–68.0	28.9–34.0	7.5–28.0	17.0	10, 23
COVID-19	14.3	26.3	16.9	20.7	24, 25

COVID-19 : coronavirus disease 2019; HD: heart disease; MERS: Middle East respiratory syndrome; SARS: severe acute respiratory syndrome.